Petrichor Healthcare Capital Management LP

Private equity with venture activitySEC-registered adviserClassification probable· New York, New YorkPETRICHORCAP.COM

Private equity with venture activity, based in New York, New York, reporting $296M of fund assets on its funds' Form ADV filings.

Composed from this organization's classification, location and filed figures.

Reported fund assets
$296M
sum of its funds' Form ADV filings, last 30 months
New companies, 12 mo
None
Investment team
14
Latest vintage
2022
As of · the latest observation of this organization; filed figures are as of its latest Form ADV

17 additional team members, 1 additional co-investor or affiliate, 15 additional investments, funds and LPs, 15 verified contacts (13 professional url, 1 general firm email, 1 firm phone)

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Nothing material in the last 180 days.

People to know

View all people
  • Founder, Managing Partner Scion
    Why: Managing partner: runs the firm
    Profile
  • Founder, Managing Partner Scion
    Why: Managing partner: runs the firm
    No route on file yet
  • Managing Member
    Why: Named with investment responsibility
    No route on file yet

Relationship network

43 connected entities

From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.

Reading the network
  • Sponsor
  • Company
  • Fund or vehicle
  • Person

Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Petrichor Healthcare Capital Management LP: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Petrichor Healthcare Capital Management LP

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Investing

18 companies on record, 0 new in 12 months
Investments on record
18 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Ascend Gene Cell Therapiesportfolio listingunknownunknownunknownunknownSep 30, 2026Fact Firm website
Aurionportfolio listingunknownunknownunknownunknownSep 30, 2026Fact Firm website
Avaloportfolio listingunknownunknownunknownunknownSep 30, 2026Fact Firm website
Stated thesis versus observed behaviour
18 observed deals
Stated (the firm’s website)
Sectors
healthcare, biotech, medtech
Stages
growth
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate no observed dealsfollow-on rate no observed dealsnew companies, 12 months 0

Team

22 current, 1 departed
Decision makers
who to call first, and why; then everyone else by function
  • Aaron Kantoff · Founder, Managing Partner Scion
    Why this person: Managing partner: runs the firm; Named with investment responsibility; Confirmed current on the firm's own site 2026-10-01
    LinkedIn or profile link on file (firm website), confirmed 2026-10-01, confidence 90%
  • Samuel Hall · Founder, Managing Partner Scion
    Why this person: Managing partner: runs the firm; Named with investment responsibility
  • Tadd Seaton Wessel · Managing Member
    Why this person: Named with investment responsibility

Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. 1 with a route on file. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.

Investment team
22 current, 1 departed
1 departed (kept with end dates)
  • Baabur Khondker · Chief Financial Officer And Chief Compliance Officer · Mar 1, 2020 to Sep 30, 2024 Inference
Contacts
1 general firm email, 1 firm phone, 13 professional url

1 general firm email, 1 firm phone, 13 professional url on record, each with its source. Values open with the complete profile.

Funds and LPs

1 vehicle, 0 LPs disclosed
Funds and vehicles
1 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Petrichor Scion Therapeutics LLCFund2022 form d first saleActive deployment$296M
Mar 31, 2026
100$172MMar 15, 2023
Limited partners
0 LPs, 0 disclosed commitments
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Known LPs and allocators
0 relationships across the firm's funds, from public pensions and the allocator graph
No allocator names this firm or its funds in a public disclosure DFX holds.

Relationships across DFX

4 co-investors · on 4 other DFX graphs
Co-investors
4 counted from shared deals, for the whole firm
Across DFX and the capital chainon 4 other DFX graphs Show
Across DFX
Across the graphs

Petrichor Healthcare Capital Management LP is the same institution as 4 records in Allocators, Independent Sponsors, Private Equity and RIA and Wealth.

Allocators1Independent Sponsors1Private Equity1RIA and Wealth1

DFX found 4 relationships across 4 datasets

Which record it is in each graph, what it is called there, and how the two were matched.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Checking your plan…

Evidence and history

4 dated events, 68 observations from 4 sources
Timeline
4 dated events
  1. Sep 30, 2024
    Baabur Mohammad Sattar Khondker (Chief Financial Officer And Chief Compliance Officer) no longer on Schedule A of Petrichor Healthcare Capital Management LP
    Person leftPeopleInferenceBaabur KhondkerForm ADV
  2. Mar 31, 2022
    Petrichor Scion Therapeutics LLC first reported on Form ADV by Petrichor Healthcare Capital Management LP (Venture Capital Fund), GAV $106,950,000
    Fund first reported on Form ADVFundsFactPetrichor Scion Therapeutics LLCForm ADV
  3. Mar 1, 2020
    Baabur Khondker joined Schedule A of Petrichor Healthcare Capital Management LP as Chief Financial Officer And Chief Compliance Officer
    Person joinedPeopleFactBaabur KhondkerForm ADV
  4. Jul 14, 2017
    Petrichor Healthcare Capital Management LP first filed Form ADV (ERA)
    First SEC adviser filingOrganizationFactForm ADV
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 31, 2026 · 4 private fundsShow
Headquarters
New York, NYadviserinfo.sec.gov
Office address
unknownadviserinfo.sec.gov
Business phone
unknownadviserinfo.sec.gov
SEC adviser type
Registered investment adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Mar 31, 2026
Private funds reported
4 (1 venture capital funds)adviserinfo.sec.gov
Private fund gross assets, adviser total
$966Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Regulatory AUM
$966Mthe adviser's RAUM, a regulatory measure, never a fund size
Employees
16
Owners on Schedule A
Phcm GP LLC (General Partner), owns under 5%
Classification history
Every classification this record has carried1 on recordShow
  1. Sep 12, 2026
    Private equity with venture activity (probable, 75%)
    Registered adviser; venture funds are 25% of 4 private funds
Evidence
75 observations from 4 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedVC funds reportedMar 31, 2026FactForm ADV
SEC adviser typeRegistered investment adviserMar 31, 2026FactForm ADV
SEC adviser typeRegistered investment adviserMar 31, 2026FactForm ADV
SEC adviser typeRegistered investment adviserSep 30, 2024FactForm ADV
First Form ADV filing2017-07-14Mar 31, 2026FactForm ADV
First Form ADV filing2017-07-14Sep 30, 2024FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-29Sep 30, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-25Sep 26, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-23Sep 24, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-21Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1+panel:2026-09-22Sep 23, 2026FactForm ADV
Adv history loadedadv-hist-1Sep 12, 2026FactForm ADV
Latest Form ADV filing2026-03-31Mar 31, 2026FactForm ADV
Latest Form ADV filing2026-03-31Mar 31, 2026FactForm ADV
Latest Form ADV filing2024-09-30Sep 30, 2024FactForm ADV
SEC statusApprovedMar 31, 2026FactForm ADV
SEC status effective2018-01-02Mar 31, 2026FactForm ADV
Venture share of reported funds0Mar 31, 2026FactForm ADV
Venture share of reported funds0Sep 30, 2024FactForm ADV
Business phoneMar 31, 2026FactForm ADV
Business phoneSep 30, 2024FactForm ADV
Contact page urlSep 30, 2026Factno URL
Contact page urlSep 16, 2026Factno URL
Employees16Mar 31, 2026FactForm ADV
Employees15Sep 30, 2024FactForm ADV
HeadquartersNew York, NYMar 31, 2026FactForm ADV
HeadquartersNew York, NYSep 30, 2024FactForm ADV
Office addressMar 31, 2026FactForm ADV
Office addressSep 30, 2024FactForm ADV
Self-described typeVenture capitalSep 30, 2026Factno URL
Self-described typeVenture capitalSep 16, 2026Factno URL
Self-described typeVenture capitalSep 15, 2026Factno URL
Legal formLimited PartnershipMar 31, 2026FactForm ADV
PE funds reported3Mar 31, 2026FactForm ADV
Portfolio pageSep 30, 2026Factno URL
Portfolio pageSep 16, 2026Factno URL
Portfolio pageSep 15, 2026Factno URL
Private funds reported4Mar 31, 2026FactForm ADV
Private funds reported4Mar 31, 2026FactForm ADV
Private funds reported4Sep 30, 2024FactForm ADV
Private fund gross assets (reported)$966MMar 31, 2026FactForm ADV
Private fund gross assets (reported)$966MMar 31, 2026FactForm ADV
Private fund gross assets (reported)$872MSep 30, 2024FactForm ADV
Regulatory AUM (adviser, not fund size)$966MMar 31, 2026FactForm ADV
Regulatory AUM (adviser, not fund size)$872MSep 30, 2024FactForm ADV
Schedule a diffsadiff-1Mar 31, 2026FactForm ADV
Stated sectorsHealthcare, biotech, medtech
“sector words on the home page”
Sep 30, 2026Factno URL
Stated sectorsHealthcare, biotech, medtech
“sector words on the home page”
Sep 16, 2026Factno URL
Stated sectorsHealthcare, biotech, medtech
“sector words on the home page”
Sep 15, 2026Factno URL
Stated stagesgrowth
“stage words on the home page”
Sep 30, 2026Factno URL
Stated stagesgrowth
“stage words on the home page”
Sep 16, 2026Factno URL
Stated stagesgrowth
“stage words on the home page”
Sep 15, 2026Factno URL
Team pageSep 30, 2026Factno URL
Team pageSep 16, 2026Factno URL
Team pageSep 15, 2026Factno URL
Venture funds reported1Mar 31, 2026FactForm ADV
Venture funds reported1Mar 31, 2026FactForm ADV
Venture funds reported1Sep 30, 2024FactForm ADV
WebsiteSep 30, 2024FactForm ADV
Site titleSep 30, 2026Factno URL
Site titleSep 16, 2026Factno URL
Site titleSep 15, 2026Factno URL
How this is scored
Scores, classification basis and filing advisersPrivate equity with venture activity, probableShow
Importance
39
elevated
Active deployment
0
low
Emerging
0
low
Freshness
100
high
Private equity with venture activity · probableSEC registered investment adviser

Registered adviser; venture funds are 25% of 4 private funds

The inputs behind each score
importance
gav: $0 · funds: 0.08 · people: 0.6 · investments: 0.47 · scale basis: Venture-typed funds only (Private equity with venture activity): 1 fund, $296M of $296M reported · co investors: 0.24
active deployment
investments 12m: 0 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: not scored
emerging manager
fund count: 1 · reported gav: $296M · first adv filing: 2017-07-14 · years since first filing: 9.2

Fits, record history and connections

scored matches for this investor, every identity change, every edge

Record history

1 dated event on the change ledger, latest event first
  • Adviser's first ADV filing
    2017-07-14source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.